Wacker Symposium – Live Microbial Products

Location:
Amsterdam

Date:
29th April 2025 to 30th April 2025

Overview Venue Apply for a place

Wacker Microbiome Forum Sponsor

WACKER -Site Visit Tuesday 29th April

Get an exclusive site tour of WACKER production facilities with the process development department.

13:30 Bus Departs 13th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum to Wacker Biotech, Amsterdam. (Travel time 60 minutes)
15:15: Welcome and introduction of Wacker Biotech: Ronald Eulenberger, Managing Director, Wacker Biotech B.V.
15:30: Keynote: Igor Mierau, Director Genetic Engineering and Manufacturing, Aurealis Therapeutics
16:30: Site tour of our production facilities
18:30: Join our dinner boatcruise in Amsterdam or return to The Hague via AMS Shiphol

Live Microbial Products Workshops Wednesday 30th April

08.30 Attend workshops designed to address key challenges and innovations in live biotherapeutics.

Innovative Analytical Methods with Tomas de Wouters, CEO, PharmaBiome: Enhancing In-Process Analytics and Ensuring Safety. Discover the latest advancements in analytical methods and explore the challenges and solutions for implementing suitable in-process analytics and ensuring safety in monoseptic environments.
Scaling Up Multi-Strain Microbial Drug Products with Shiri Meshner, VP R&D, Biomica: Co-Cultivation Strategies and Alternative Strategies. Learn about cutting-edge strategies for making co-cultivation a viable option at production scale, and discuss the benefits and challenges of multi-strain microbial drug products.
From Discovery to Commercialization with Céline Druart, Executive Director, Pharmabiotic Research Institute: Building a Scalable and Controlled GMP Manufacturing Process. Gain insights into the essential steps for developing a scalable, well-characterized, and controlled GMP manufacturing process, from initial discovery through to commercialization

12:15 Lunch with experts @ Wacker Biotech, Amsterdam

Don’t miss this opportunity to network with industry experts, share insights, and explore the latest advancements in biotherapeutic products.

Registration is subject to final approval from Wacker.

Venue

Wacker Biotech

Wacker Biotech B.V. Amsterdam is the full-service contract manufacturer and centre of excellence for live microbial products, vaccines and biopharmaceutical proteins based on microbial systems. Additionally, the facility provides capabilities for developing mRNA-based processes and GMP manufacturing of customized mRNA processes. The GMP production site is certified up to Biosafety Level 2 in accordance with Good Manufacturing Practice (GMP) and complies with the requirements stipulated by the European and US drug-approval authorities (EMA and FDA, respectively). Together with four other Wacker Biotech production sites, the company is a subsidiary of the biopharma division of Wacker Chemie AG.